Tayebe Shamsizadeh Meymandi
Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
[ 1 ] - The Effect of Intravenous Tocilizumab Therapy on the Prognosis of Patients with Covid-19: A Case-control Study
Background and Objective: Tocilizumab is a monoclonal antibody against the Interleukin-6 (IL6) receptor, but its effect on improving the clinical condition of coronavirus disease of 2019 (COVID-19) patients is debated. Accordingly, this study investigated the impact of Tocilizumab as an alternative treatment on the outcomes of covid-19 patients. Methods: In this retrospective case-control stud...